Grifols Partnership
Small molecule injectable CDMO with 100+ years of parenteral expertise
Listed on cdmo.directory
CDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise. Headquartered in Sant Cugat del Vallès, Spain.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Development (D)
Manufacturing (M)
Fill-finish formats
Services
Indications
About this organization
Grifols Partnership is a contract development and manufacturing platform (CDMO) specialized in added-value injectable products for small molecules. The organization offers development and manufacturing services spanning from vial containers to premixed solutions, with particular expertise in intravenous products and parenteral formulations (both concentrated and diluted).
Key Capabilities:
- Small molecule injectable product development and manufacturing
- Parenteral formulation expertise (concentrated and diluted solutions)
- Intravenous product manufacturing
- Technology transfer for parenteral products
- Full development-to-manufacturing continuity
Differentiation: Grifols Partnership combines the resources and regulatory compliance infrastructure of a large organization with personalized service and flexibility. The company emphasizes long-term partnerships, on-time and on-budget delivery, and responsive communication. With over 100 years of Grifols heritage, the organization brings established manufacturing capacity, regulatory expertise, and global experience to injectable product development.
Locations
Headquarters
Sant Cugat del Vallès · Catalonia · Spain
Submit a verified review for this organization.
Markdown mirror: /companies/grifols.md